Aion Therapeutic (XCNQ:AION) Interest Expense : C$-0.15 Mil (TTM As of Jan. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Aion Therapeutic Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Aion Therapeutic's interest expense for the three months ended in Jan. 2024 was C$ -0.05 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jan. 2024 was C$-0.15 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Aion Therapeutic's Operating Income for the three months ended in Jan. 2024 was C$ -0.24 Mil. Aion Therapeutic's Interest Expense for the three months ended in Jan. 2024 was C$ -0.05 Mil. Aion Therapeutic did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Aion Therapeutic Interest Expense Historical Data

The historical data trend for Aion Therapeutic's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aion Therapeutic Interest Expense Chart

Aion Therapeutic Annual Data

Trend

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Interest Expense

Get a 7-Day Free Trial

-0.68

-0.32

-0.19

-0.08

-0.15

Aion Therapeutic Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Interest Expense	Get a 7-Day Free Trial															-0.04	-0.03	-0.03	-0.04	-0.05

Aion Therapeutic Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.15 Mil.

Aion Therapeutic (XCNQ:AION) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Aion Therapeutic's Interest Expense for the three months ended in Jan. 2024 was C$-0.05 Mil. Its Operating Income for the three months ended in Jan. 2024 was C$-0.24 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jan. 2024 was C$0.00 Mil.

Aion Therapeutic's Interest Coverage for the quarter that ended in Jan. 2024 is calculated as

Aion Therapeutic did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Aion Therapeutic (XCNQ:AION) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aion Therapeutic Inc (XCNQ:AION) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

ANTCF:USA

Address

700 West Georgia Street, Suite 2200, Vancouver, BC, CAN, V7Y 1K8

Website

https://www.aiontherapeutic.com

Aion Therapeutic Inc is in the business of research and development, treatment, data mining, and state of the art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals, and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery.

Executives

Ismail Abdul Fattah

Director or Senior Officer of 10% Security Holder

Aion Therapeutic (XCNQ:AION) Headlines

No Headlines